Effects of the endothelin ET(A) receptor antagonist, TA-0201, on pulmonary arteries isolated from hypoxic rats

European Journal of Pharmacology

Volumn 376, Issue 3, 1999, Pages 233-238

  Itoh, Hiroo ^a   Yokochi, Ayumu ^b   Yamauchi Kohno, Rikako ^c   Maruyama, Kazuo ^b  

^a Suzuka Kaisei Gen Hosp 5 23 18 J   (Japan)

^b MIE UNIVERSITY   (Japan)

^c Discovery Research Laboratory   (Japan)

Author keywords

Endothelin 1; Hypoxia; Pulmonary hypertension

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN A RECEPTOR ANTAGONIST; N [6 [2 (5 BROMO 2 PYRIMIDINYLOXY)ETHOXY] 5 (4 METHYLPHENYL) 4 PYRIMIDINYL] 4 (2 HYDROXY 1,1 DIMETHYLETHYL)BENZENESULFONAMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; HEART RIGHT VENTRICLE HYPERTROPHY; HYPOXIA; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT;

ANIMALS; ANOXIA; ENDOTHELIN-1; HYPERTENSION, PULMONARY; MALE; PULMONARY ARTERY; PYRIMIDINES; RATS; RATS, WISTAR; RECEPTOR, ENDOTHELIN A; RECEPTORS, ENDOTHELIN; SULFONAMIDES; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 0032990808     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00380-5     Document Type: Article

References (20)

1. Arai H., Hori S., Aramori I., Ohkubo H., Nakanishi S. Cloning and expression of a cDNA encoding and endothelin receptor. Nature. 348:1990;730-732.
2. A-receptor antagonist, attenuates hypoxic pulmonary hypertension. Am. J. Physiol. 266:1994;H1327-H1331.
3. Chen S.J., Chen Y.F., Meng Q.C., Durand J., Dicarlo V.S., Oparil S. Endothelin-receptor antagonist, bosentan prevents and reverses hypoxic pulmonary hypertension in rat. J. Appl. Physiol. 79:1995;2122-2131.
4. Clozel M., Breu V., Gray G.A., Kalina B., Löffler B.M., Burri K., Cassal J.M., Müller M., Neidhart W., Ramuz H. Pharmacological characterization of bosentan, a new orally active non-peptide endothelin receptor antagonist. J. Pharmacol. Exp. Ther. 270:1994;228-235.
5. Dubin D., Pratt R.E., Dzau V.J. Endothelin, a potent vasoconstrictor, is a vascular smooth muscle mitogen. J. Vasc. Med. Biol. 1:1989;150-154.
6. Eddahibi S., Raffestin B., Clozel M., Levame M., Adnot S. Protection from pulmonary hypertension with an orally active endothelin receptor antagonist in hypoxic rats. Am. J. Physiol. 268:1995;H828-H835.
7. Furchgott R.F., Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 288:1980;373-376.
8. Giaid A., Yanagisawa M., Langleben D., Michell R.P., Levy R., Shennib H., Kimura S., Masaki T., Duguid W.P., Stewart D.J. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N. Engl. J. Med. 328:1993;1732-1739.
9. Hirata Y., Yoshimi H., Takaichi S., Yanagisawa M., Masaki T. Binding and receptor down-regulation of a novel vasoconstrictor endothelin in cultured rat vascular smooth muscle cells. FEBS Lett. 239:1988;13-17.
10. Hoshino T., Yamauchi R., Kikkawa K., Yabana H., Murata S. Pharmacological profile of T-0201, a highly potent and orally active endothelin receptor antagonist. J. Pharmacol. Exp. Ther. 286:1998;643-649.
11. A receptor. Life Sci. 50:1992;247-255.
12. Li H., Chen S.J., Chen Y.F., Meng Q.C., Durand J., Oparil S., Elton T.S. Enhanced endothelin-1 and endothelin receptor gene expression in chronic hypoxia. J. Appl. Physiol. 77:1994;1451-1459.
13. Maruyama J., Maruyama K. Impaired nitric oxide-dependent responses and their recovery in hypertensive pulmonary arteries of rats. Am. J. Physiol. 266:1994;H2476-H2488.
14. Miasiro N., Paiva A.C. Homologous desensitization of the effects of endothelin on rabbit aorta rings and on cultured rat aorta smooth muscle cells. Eur. J. Pharmacol. 179:1990;151-158.
15. Miyauchi T., Yorikane R., Sakai S., Sakurai T., Okada M., Nishikibe M., Yano M., Yamaguchi I., Sugishita Y., Goto K. Contribution of endogenous endothelin-1 to the progression of cardio pulmonary alterations in rats with monocrotaline-induced pulmonary hypertension. Circ. Res. 73:1993;887-897.
16. Roubert P., Gillard V., Plas P., Chabrier P.E., Braquet P. Down regulation of endothelin binding sites in rat vascular smooth muscle cells. Am. J. Hypertens. 3:1990;310-312.
17. Sakurai T., Yanagisawa M., Takuwa Y., Miyazaki H., Kimura S., Goto K., Masaki T. Cloning of cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature. 348:1990;732-735.
18. Stelzner T.J., O'Brien R.F., Yanagisawa M., Sakurai T., Sato K., Webb S., Zamora M., McMurtry I.F., Fisher J.H. Increased lung endothelin-1 production in rats with idiopathic pulmonary hypertension. Am. J. Physiol. 262:1992;L614-L620.
19. Stewart D.J., Levy R.P., Cernacek P., Langleben D. Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? Ann. Intern. Med. 114:1991;464-469.
20. Yanagisawa M., Kurhara H., Kimura S., Tomobe Y., Kobayashi M., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332:1988;411-415.